Transcriptome profiles of AML cell lines aftere treatment of OR-21 (a novel dimethylating agent), venetoclax, and combination
In order to examine the molecular mechnism of the combined anti-tumor effect of OR-21 and venetoclax, we analyzed the transcriptome profiles of AML cell lines (HL60 and KG1a) treated with vehicle, OR-21, venetoclax, and OR21 plus venetoclax.